Allurion Technologies Inc. (ALUR)

Market Cap	27.45M
Revenue (ttm)	34.75M
Net Income (ttm)	-24.76M
Shares Out	78.89M
EPS (ttm)	-0.48
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	640,523
Open	0.315
Previous Close	0.280
Day's Range	0.280 - 0.356
52-Week Range	0.260 - 4.000
Beta	-0.60
Analysts	Strong Buy
Price Target	3.00 (+762.07%)
Earnings Date	Nov 13, 2024

About ALUR

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2009
• Employees: 504
• Stock Exchange: NYSE
• Ticker Symbol: ALUR
• Website: https://www.allurion.com

Financial Performance

In 2023, Allurion Technologies's revenue was $53.47 million, a decrease of -16.73% compared to the previous year's $64.21 million. Losses were -$82.30 million, 102.5% more than in 2022.

Analyst Forecast

According to 4 analysts, the average rating for ALUR stock is "Strong Buy." The 12-month stock price forecast is $3.0, which is an increase of 762.07% from the latest price.

Price Target

$3.0

(762.07% upside)

Analyst Consensus: Strong Buy